Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | DPYD | Q12882 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrazole SCHEMBL8198854 | 0.82 | GAA (0.36) | GAADPYDMAPTALDH1A1ATAD2 | |
| SCHEMBL5751524 | 0.78 | DPYD (0.45) | GAADPYDMAPTALDH1A1ATAD2 | |
| SCHEMBL6684769 | 0.78 | ATAD2 (0.50) | GAADPYDMAPTALDH1A1ATAD2 | |
| SCHEMBL65085 | 0.67 | — | — | |
| 5-Bromouracil SCHEMBL29805 | 0.67 | — | — | |
| SCHEMBL5801644 | 0.66 | ALDH1A1 (0.64) | GAADPYDMAPTALDH1A1ATAD2 | |
| SCHEMBL18783134 | 0.65 | DPYD (0.50) | GAADPYDMAPTALDH1A1ATAD2 | |
| Potassium SCHEMBL29524710 | 0.65 | DPYD (0.50) | GAADPYDMAPTALDH1A1ATAD2 | |
| Hydrochloric Acid SCHEMBL29256236 | 0.65 | DPYD (0.50) | GAADPYDMAPTALDH1A1ATAD2 | |
| SCHEMBL6573722 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12054768-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-06 | — | — | US | disclosed |
| EP-4123031-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | The Regents of The University of California (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-3283638-B1 | METHODS FOR DETECTING AGGLUTINATION AND USE OF KITS IN PRACTICING THE SAME | UNIV CALIFORNIA (US) | 2022-06-08 | — | — | EP | disclosed |
| CN-106543049-B | Sulfamido haptens and its preparation method and the application for combining antigen | 中国农业大学 | 2018-09-14 | — | — | CN | disclosed |
| CN-106543049-A | The preparation method of sulfonamides hapten and its conjugated antigen and application | 中国农业大学 | 2017-03-29 | — | — | CN | disclosed |
| CN-103169708-A | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds | RIGEL PHARMACEUTICALS INC | 2013-06-26 | — | — | CN | disclosed |
| WO-2009018132-A9 | METHODS AND SYSTEMS FOR ATTENUATING THE TOLERANCE RESPONSE TO A DRUG | NEUROVISTA CORP (US) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009018132-A2 | METHODS AND SYSTEMS FOR ATTENUATING THE TOLERANCE RESPONSE TO A DRUG | NEUROVISTA CORPORATION (US) | 2009-02-05 | — | — | WO | disclosed |
| US-20090030403-A1 | Methods and Systems for Attenuating the Tolerance Response to a Drug | CYBERONICS, INC. | 2009-01-29 | — | — | US | disclosed |
| CN-1625400-A | 2, 4-pyrimidinediamine compounds and uses thereof | RIGEL PHARMACEUTICALS INC (US) | 2005-06-08 | — | — | CN | disclosed |